MPN-384 A Phase 2 Study of Pemigatinib (FIGHT-203; INCB054828) in Patients With Myeloid/Lymphoid Neoplasms With Fibroblast Growth Factor Receptor 1 (FGFR1) Gene Rearrangement
Autor: | Vannucchi, Alessandro M., Patel, Jay L., Shomali, William E., George, Tracy I., Reiter, Andreas, Rambaldi, Alessandro, Oh, Stephen, Usuki, Kensuke, Harrison, Claire N., Luisa Veronese, Maria, Gilmartin, Aidan, Zhen, Huiling, Verstovsek, Srdan, Oliveira, Natalia, Gotlib, Jason, Kiladjian, Jean-Jacques |
---|---|
Zdroj: | In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S430-S431 |
Databáze: | ScienceDirect |
Externí odkaz: |